SysLogic wins FDA approval for blood device; Mystery med tech tenant buys big in CA;

@FierceMedDev: Luminex re-ups assay deal with Merck KGaA. News | Follow @FierceMedDev

@DamianFierce: Cyberonics slides after CMS again rejects depression device for reimbursement. Article | Follow @DamianFierce

> Colorado's Lanx has launched its Timberline MPF spinal plate fixation system, the first modular anchored interbody device for lateral fusion. News

> SysLogic won FDA approval for iTrace, a device that uses radio frequency identification to track blood samples and prevent the release of unsuitable blood components. More

> Maryland startup BioElectronics pulled in $500,000 in working capital to amp up production of its consumer medical devices for pain treatment, surgical procedure and wound care. Item

> Spinal Elements has licensed patents to develop lateral spine access devices, allowing the company to work on minimally invasive surgical technologies. Release

> A mystery life sciences company worth up to $10 billion is moving into 97,700 square feet of R&D space in San Francisco, and the unnamed tenant could well be a local heavyweight like Illumina ($ILMN) or BioMarin. Article

> A former Covidien ($COV) employee has been charged with heisting hydrocodone tablets from a company plant in New York. Story

Biotech News

@FierceBiotech: GSK buys Okairos (Fierce 15 profile) for $325M, strengthens vaccines biz. Release | Follow @FierceBiotech

@JohnCFierce: Novo spearheads $175M financing to back Ophthotech's PhIII AMD study. News | Follow @JohnCFierce

@RyanMFierce: UPDATED: GlaxoSmithKline bags genetic vaccine developer Okairos for $325M. Article | Follow @RyanMFierce

@EmilyMFierce: University of Alabama begins Parkinson's biomarker study. Story | Follow @EmilyMFierce

> Alexandria lands anchor R&D tenant for San Francisco biotech cluster. Article

> GenVec seeks liquidation after gene therapy setbacks. Report

> Novo spearheads $175M financing to back Ophthotech's PhIII AMD study. More

> Sights set on Asia, Amgen sets up JV development deal with Astellas. News

Pharma News

@FiercePharma: More Indian hospitals eye anti-Ranbaxy policies, Business Standard reports. Some patients asking to switch. Report | Follow @FiercePharma

 @EricPFierce: U.S. arrests 2 Pakistani men for selling controlled substances via the Internet. Interpol tracks them to London. Story | Follow @EricPFierce

 @CarlyHFierce: First Ranbaxy, now Wockhardt - what is India to do about its manufacturing problems? Regulators unsure. More | Follow @CarlyHFierce

> Re-analyzed Avandia data shows no increased heart risks. Report

> Big Kahuna statins gobble up bigger share of cholesterol market. Story

> Amgen forges ahead in Japan with Astellas joint venture. News

Biomarkers News

> New CTC technology looks promising to track evolution of prostate cancer. Report

> Swedish team discovers protein common to aggressive bladder cancer. More

> Cenix to collaborate with Debiopharm on predictive biomarkers. Article

> Pancreatitis or cancer? Mayo Clinic says mutated gene points the way. Story

> Johns Hopkins: Two genes help predict postpartum depression risk. Item

Drug Delivery News

 @MichaelGFierce: Morphine delivery platform could diminish abuse potential. Item | Follow @MichaelGFierce

> Shape-shifting nanoparticles anchor to tumor cells, deliver drugs. Story

> New drug targets lock-and-key mechanism of prostate cancer growth. Article

> Covidien completes successful drug-coated balloon trial. More

> Inhalable chemo-carrying nanoparticles target lung cancer directly. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.